333 related articles for article (PubMed ID: 21300911)
1. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells.
Saito M; Nagasawa M; Takada H; Hara T; Tsuchiya S; Agematsu K; Yamada M; Kawamura N; Ariga T; Tsuge I; Nonoyama S; Karasuyama H; Minegishi Y
J Exp Med; 2011 Feb; 208(2):235-49. PubMed ID: 21300911
[TBL] [Abstract][Full Text] [Related]
2. SH2-domain mutations in STAT3 in hyper-IgE syndrome patients result in impairment of IL-10 function.
Giacomelli M; Tamassia N; Moratto D; Bertolini P; Ricci G; Bertulli C; Plebani A; Cassatella M; Bazzoni F; Badolato R
Eur J Immunol; 2011 Oct; 41(10):3075-84. PubMed ID: 21792878
[TBL] [Abstract][Full Text] [Related]
3. Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.
Al Khatib S; Keles S; Garcia-Lloret M; Karakoc-Aydiner E; Reisli I; Artac H; Camcioglu Y; Cokugras H; Somer A; Kutukculer N; Yilmaz M; Ikinciogullari A; Yegin O; Yüksek M; Genel F; Kucukosmanoglu E; Baki A; Bahceciler NN; Rambhatla A; Nickerson DW; McGhee S; Barlan IB; Chatila T
J Allergy Clin Immunol; 2009 Aug; 124(2):342-8, 348.e1-5. PubMed ID: 19577286
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
[TBL] [Abstract][Full Text] [Related]
5. Genetic origins of hyper-IgE syndrome.
Minegishi Y; Karasuyama H
Curr Allergy Asthma Rep; 2008 Sep; 8(5):386-91. PubMed ID: 18682102
[TBL] [Abstract][Full Text] [Related]
6. Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.
Becker KL; Rösler B; Wang X; Lachmandas E; Kamsteeg M; Jacobs CW; Joosten LA; Netea MG; van de Veerdonk FL
Clin Exp Allergy; 2016 Dec; 46(12):1564-1574. PubMed ID: 27474157
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome.
Minegishi Y; Saito M
Ann N Y Acad Sci; 2011 Dec; 1246():34-40. PubMed ID: 22236428
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern.
Boos AC; Hagl B; Schlesinger A; Halm BE; Ballenberger N; Pinarci M; Heinz V; Kreilinger D; Spielberger BD; Schimke-Marques LF; Sawalle-Belohradsky J; Belohradsky BH; Przybilla B; Schaub B; Wollenberg A; Renner ED
Allergy; 2014 Jul; 69(7):943-53. PubMed ID: 24898675
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of Hyper IgE syndrome.
Minegishi Y; Saito M
Allergol Int; 2012 Jun; 61(2):191-6. PubMed ID: 22441639
[TBL] [Abstract][Full Text] [Related]
11. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.
Kreins AY; Ciancanelli MJ; Okada S; Kong XF; Ramírez-Alejo N; Kilic SS; El Baghdadi J; Nonoyama S; Mahdaviani SA; Ailal F; Bousfiha A; Mansouri D; Nievas E; Ma CS; Rao G; Bernasconi A; Sun Kuehn H; Niemela J; Stoddard J; Deveau P; Cobat A; El Azbaoui S; Sabri A; Lim CK; Sundin M; Avery DT; Halwani R; Grant AV; Boisson B; Bogunovic D; Itan Y; Moncada-Velez M; Martinez-Barricarte R; Migaud M; Deswarte C; Alsina L; Kotlarz D; Klein C; Muller-Fleckenstein I; Fleckenstein B; Cormier-Daire V; Rose-John S; Picard C; Hammarstrom L; Puel A; Al-Muhsen S; Abel L; Chaussabel D; Rosenzweig SD; Minegishi Y; Tangye SG; Bustamante J; Casanova JL; Boisson-Dupuis S
J Exp Med; 2015 Sep; 212(10):1641-62. PubMed ID: 26304966
[TBL] [Abstract][Full Text] [Related]
12. Human rhinoviruses induce IL-35-producing Treg via induction of B7-H1 (CD274) and sialoadhesin (CD169) on DC.
Seyerl M; Kirchberger S; Majdic O; Seipelt J; Jindra C; Schrauf C; Stöckl J
Eur J Immunol; 2010 Feb; 40(2):321-9. PubMed ID: 19950173
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells.
Gonzalez-Rey E; Chorny A; Fernandez-Martin A; Ganea D; Delgado M
Blood; 2006 May; 107(9):3632-8. PubMed ID: 16397128
[TBL] [Abstract][Full Text] [Related]
14. The STATus of PD-L1 (B7-H1) on tolerogenic APCs.
Sumpter TL; Thomson AW
Eur J Immunol; 2011 Feb; 41(2):286-90. PubMed ID: 21267998
[TBL] [Abstract][Full Text] [Related]
15. Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndrome.
van de Veen W; Krätz CE; McKenzie CI; Aui PM; Neumann J; van Noesel CJM; Wirz OF; Hagl B; Kröner C; Spielberger BD; Akdis CA; van Zelm MC; Akdis M; Renner ED
Allergy; 2019 Dec; 74(12):2394-2405. PubMed ID: 31269238
[TBL] [Abstract][Full Text] [Related]
16. Expansion of T helper type 17 lymphocytes in patients with chronic granulomatous disease.
Horváth R; Rožková D; Lašťovička J; Poloučková A; Sedláček P; Sedivá A; Spíšek R
Clin Exp Immunol; 2011 Oct; 166(1):26-33. PubMed ID: 21910722
[TBL] [Abstract][Full Text] [Related]
17. Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation.
Siegel AM; Stone KD; Cruse G; Lawrence MG; Olivera A; Jung MY; Barber JS; Freeman AF; Holland SM; O'Brien M; Jones N; Nelson CG; Wisch LB; Kong HH; Desai A; Farber O; Gilfillan AM; Rivera J; Milner JD
J Allergy Clin Immunol; 2013 Dec; 132(6):1388-96. PubMed ID: 24184145
[TBL] [Abstract][Full Text] [Related]
18. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.
Milner JD; Brenchley JM; Laurence A; Freeman AF; Hill BJ; Elias KM; Kanno Y; Spalding C; Elloumi HZ; Paulson ML; Davis J; Hsu A; Asher AI; O'Shea J; Holland SM; Paul WE; Douek DC
Nature; 2008 Apr; 452(7188):773-6. PubMed ID: 18337720
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic signaling by pulmonary CD1c+ dendritic cells induces regulatory T cells in patients with chronic obstructive pulmonary disease by IL-27/IL-10/inducible costimulator ligand.
Tsoumakidou M; Tousa S; Semitekolou M; Panagiotou P; Panagiotou A; Morianos I; Litsiou E; Trochoutsou AI; Konstantinou M; Potaris K; Footitt J; Mallia P; Zakynthinos S; Johnston SL; Xanthou G
J Allergy Clin Immunol; 2014 Oct; 134(4):944-954.e8. PubMed ID: 25051954
[TBL] [Abstract][Full Text] [Related]
20. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML; Freeman AF; Holland SM
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
